Paper30833429
Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.
Kloprogge F and 6 others. Antimicrob Agents Chemother, 2019. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model. Papers, record 30833429. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30833429
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Vancomycin | Major topic |
| Child | |
| Child, Preschool | |
| Female | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Logistic Models | |
| Male | |
| Microbial Sensitivity Tests | |
| Multivariate Analysis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/M008665/1 | Medical Research Council | United Kingdom | PubMed | |
| MR/P014534/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28474732 | The Nephrotoxicity of Vancomycin. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28474732 | PubMed |
| 2 | 27270281 | Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27270281 | PubMed |
| 3 | 20385872 | Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20385872 | PubMed |
| 4 | 18846389 | Human renal function maturation: a quantitative description using weight and postmenstrual age. | Pediatr Nephrol | 2009 | https://conductscience.org/library/papers/18846389 | PubMed |
| 5 | 27999035 | Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board? | J Antimicrob Chemother | 2017 | https://conductscience.org/library/papers/27999035 | PubMed |
| 6 | 27767204 | Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful? | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/27767204 | PubMed |
| 7 | 26582878 | Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children. | J Pediatric Infect Dis Soc | 2015 | https://conductscience.org/library/papers/26582878 | PubMed |
| 8 | 26953202 | Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26953202 | PubMed |
| 9 | 23420517 | Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. | Clin Pharmacokinet | 2013 | https://conductscience.org/library/papers/23420517 | PubMed |
| 10 | 25998107 | Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates. | Infect Dis Ther | 2015 | https://conductscience.org/library/papers/25998107 | PubMed |
| 11 | 29285245 | A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants. | Oncotarget | 2017 | https://conductscience.org/library/papers/29285245 | PubMed |
| 12 | 27884052 | Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics. | CPT Pharmacometrics Syst Pharmacol | 2017 | https://conductscience.org/library/papers/27884052 | PubMed |
| 13 | 27631462 | Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization. | Ther Drug Monit | 2016 | https://conductscience.org/library/papers/27631462 | PubMed |
| 14 | 24579085 | Serum and urinary NGAL in septic newborns. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24579085 | PubMed |
| 15 | 21217178 | Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. | Clin Infect Dis | 2011 | https://conductscience.org/library/papers/21217178 | PubMed |
| 16 | 15509186 | Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. | Clin Pharmacokinet | 2004 | https://conductscience.org/library/papers/15509186 | PubMed |
| 17 | 29675639 | Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/29675639 | PubMed |
| 18 | 23340565 | Improved vancomycin dosing in children using area under the curve exposure. | Pediatr Infect Dis J | 2013 | https://conductscience.org/library/papers/23340565 | PubMed |
| 19 | 23439463 | Pediatric Risk, Injury, Failure, Loss, End-Stage renal disease score identifies acute kidney injury and predicts mortality in critically ill children: a prospective study. | Pediatr Crit Care Med | 2013 | https://conductscience.org/library/papers/23439463 | PubMed |
| 20 | 24663023 | Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24663023 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42792002 | Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42792002 | PubMed |
| 42750196 | Multisite Analysis of Vancomycin Concentration Predictions in a Bayesian Software in Adult and Pediatric Patients With and Without Acute Kidney Injury. | Pharmacotherapy | 2026 | https://conductscience.org/library/papers/42750196 | PubMed |
| 42508420 | Population Pharmacokinetic and Exposure-Response Analysis of Vancomycin Nephrotoxicity in Cystic Fibrosis Patients. | Pediatr Pulmonol | 2026 | https://conductscience.org/library/papers/42508420 | PubMed |
| 42387116 | Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling. | Pharm Res | 2026 | https://conductscience.org/library/papers/42387116 | PubMed |
| 42183861 | Case report: Delayed onset rash, delirium, and cross allergic reactions caused by sequential administration of cefoperazone sulbactam, meropenem, and piperacillin tazobactam. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42183861 | PubMed |
| 42118093 | Model-informed precision dosing of vancomycin in children 3 months to 18 years of age using Australia-wide data. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42118093 | PubMed |
| 42082885 | Precision Dosing of Vancomycin: A Systematic Review of Population Pharmacokinetics Models and Comparative Evaluation of Software Tools. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/42082885 | PubMed |
| 41873632 | Systematic review and scoring-based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41873632 | PubMed |
| 41015987 | Pharmacodynamics of Vancomycin Against Coagulase-Negative Staphylococci Bloodstream Infections. | Pharmacol Res Perspect | 2025 | https://conductscience.org/library/papers/41015987 | PubMed |
| 41001338 | Pharmacovigilance practice on off-label high-dose of vancomycin in severely ill children. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41001338 | PubMed |
| 39903655 | Prediction of Vancomycin Area Under the Curve With Trough Concentrations Only: Performance Evaluation of Pediatric Population Pharmacokinetic Models. | J Infect Dis | 2025 | https://conductscience.org/library/papers/39903655 | PubMed |
| 36471223 | Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood Levels. | Clin Pharmacokinet | 2023 | https://conductscience.org/library/papers/36471223 | PubMed |
| 36404388 | Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set. | Clin Pharmacokinet | 2023 | https://conductscience.org/library/papers/36404388 | PubMed |
| 36091788 | Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36091788 | PubMed |
| 35845555 | Population Pharmacokinetics and Pharmacodynamics of Vancomycin in Pediatric Patients With Various Degrees of Renal Function. | J Pediatr Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35845555 | PubMed |
| 34750740 | Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review. | Eur J Drug Metab Pharmacokinet | 2022 | https://conductscience.org/library/papers/34750740 | PubMed |
| 34671937 | An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/34671937 | PubMed |
| 34484661 | Changes of renal transporters in the kinetic process of VCM-induced nephrotoxicity in mice. | Toxicol Res (Camb) | 2021 | https://conductscience.org/library/papers/34484661 | PubMed |
| 34002357 | Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/34002357 | PubMed |
| 33466764 | Amikacin or Vancomycin Exposure Alters the Postnatal Serum Creatinine Dynamics in Extreme Low Birth Weight Neonates. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/33466764 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30833429
GET https://conductscience.org/api/papers/v1/30833429/references?page=2